A Swedish Regulatory Perspective on European Risk Management

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.2, 2007-01, pp. : 131-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Management: A European Regulatory Perspective

By Moseley J.N.S.

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 499-508

Adis International

Access to resources Recommend Favorite

Risk Management from an Asian/Pacific Rim Regulatory Perspective

By McEwen J.

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 491-497

Adis International

Access to resources Recommend Favorite

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B. Smyth Rosalind L.

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite

Role of Modelling and Simulation: A European Regulatory Perspective

By Jönsson Siv Henningsson Anja Edholm Monica Salmonson Tomas

Clinical Pharmacokinetics, Vol. 51, Iss. 2, 2012-02 ,pp. : 69-76

Adis International

Access to resources Recommend Favorite

Non-Clinical Development of Fixed Combinations: A European Regulatory Perspective

By Ulla Liminga Beatriz Silva Lima

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 135-138

Adis International

Access to resources Recommend Favorite